Condition: Diffuse Large B-Cell Lymphoma (DLBCL) · Sponsor: Ou Bai, MD/PHD
Efficacy and safety of chidamide in combination with the R-mini CHOP regimen, followed by chidamide plus CD20 monoclonal antibody as maintenance therapy, in elderly patients with newly diagnosed MYC/BCL2 double-expressor DLBCL.
This description comes directly from the study's public registry record.
Ou Bai, PHD · 13039046656 · oubai16@163.com
Always discuss trial participation with your own doctor first.
| The First Bethune Hospital of Jilin University | Changchun, Jilin, China | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07493148